AILUX Trademark

Trademark Overview


On Wednesday, November 22, 2023, a trademark application was filed for AILUX with the United States Patent and Trademark Office. The USPTO has given the AILUX trademark a serial number of 98282666. The federal status of this trademark filing is REGISTERED as of Tuesday, July 22, 2025. This trademark is owned by Jingtai Zhiyao Technology (Shanghai) Co., Ltd.. The AILUX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and development; Biomedical research services; Cloud computing featuring software for use in the field of antibody development, medical research and drug discovery; Cloud storage services for electronic data; Conducting early evaluations in the field of new pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials, antibody optimization and macromolecule drug discovery; Development of pharmaceutical preparations and medicines; DNA sequencing technology research; Drug discovery services; Medical laboratory services; Medical research; Pharmaceutical drug development services; Pharmaceutical product evaluation; Research and development of new products for others; Research and development services in the field of antibodies; Research in the field of artificial intelligence; Research in the field of chemistry; Research on the subject of pharmaceuticals
ailux

General Information


Serial Number98282666
Word MarkAILUX
Filing DateWednesday, November 22, 2023
Status700 - REGISTERED
Status DateTuesday, July 22, 2025
Registration Number7871695
Registration DateTuesday, July 22, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements


Goods and ServicesBiochemical research and development; Biomedical research services; Cloud computing featuring software for use in the field of antibody development, medical research and drug discovery; Cloud storage services for electronic data; Conducting early evaluations in the field of new pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of clinical trials, antibody optimization and macromolecule drug discovery; Development of pharmaceutical preparations and medicines; DNA sequencing technology research; Drug discovery services; Medical laboratory services; Medical research; Pharmaceutical drug development services; Pharmaceutical product evaluation; Research and development of new products for others; Research and development services in the field of antibodies; Research in the field of artificial intelligence; Research in the field of chemistry; Research on the subject of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 16, 2024
Primary Code042
First Use Anywhere DateTuesday, January 16, 2024
First Use In Commerce DateTuesday, January 16, 2024

Trademark Owner History


Party NameSHANGHAI AILUX BIOTECHNOLOGY CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressSHANGHAI 201315
CN

Party NameJingtai Zhiyao Technology (Shanghai) Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressShanghai 201000
CN

Party NameJingtai Zhiyao Technology (Shanghai) Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressShanghai 201000
CN

Party NameJingtai Zhiyao Technology (Shanghai) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai 201000
CN

Trademark Events


Event DateEvent Description
Wednesday, November 29, 2023NEW APPLICATION ENTERED
Tuesday, January 16, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 17, 2024ASSIGNED TO EXAMINER
Thursday, June 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 14, 2025TEAS STATEMENT OF USE RECEIVED
Thursday, June 12, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, March 14, 2025USE AMENDMENT FILED
Friday, June 13, 2025STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 2, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 16, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 22, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, July 22, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, October 27, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 27, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 27, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 27, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, December 31, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP